Showing results (521-530 of 3,148) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|December 11, 2023
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trialMaximilian Y Deng, Sybren L N Maas, Felix Hinz, et al.
Neuro-Oncology|December 9, 2023
Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001Hua-Ren R Cherng, Kai Sun, Søren Bentzen, et al.
Neuro-Oncology|November 7, 2023
Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade gliomaJohn DeSisto, Andrew M Donson, Andrea M Griesinger, et al.
Neuro-Oncology|May 29, 2024
Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumorsNicholas S Cho, Viên Lam Le, Francesco Sanvito, et al.
Neuro-Oncology|June 10, 2024
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapyMin Hye Noh, Jin Muk Kang, Alexandra A Miller, et al.
Neuro-Oncology|June 1, 2024
Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recoveryYae Won Park, Geon Jang, Si Been Kim, et al.
Neuro-Oncology|July 11, 2024
Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axisShaojian Lin, Liangbo Wang, Changxi Han, et al.
Neuro-Oncology|July 10, 2024
IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastomaAndrew J Hou, Ryan M Shih, Benjamin R Uy, et al.
Neuro-Oncology|July 9, 2024
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumorsBrian Golbourn, Ben Ho, Andrew Bondoc, et al.
Neuro-Oncology|July 8, 2024
Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibromaHyery Kim, Hee Mang Yoon, Eun Key Kim, et al.
Pageof 315